middle.news
Race Oncology Activates First Hong Kong Site for RC220 Solid Tumour Trial
9:30am on Tuesday 2nd of September, 2025 AEST
•
Healthcare
Read Story
Race Oncology Activates First Hong Kong Site for RC220 Solid Tumour Trial
9:30am on Tuesday 2nd of September, 2025 AEST
Key Points
Queen Mary Hospital in Hong Kong activated for RC220 Phase 1 trial
Patient enrolment commenced with first treatment expected this month
Second Hong Kong site, Prince of Wales Hospital, to activate soon
Trial progressing cautiously in Australia with two patients treated
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE